CN105395930A - Antisepsis and anti-inflammation drug for external use - Google Patents

Antisepsis and anti-inflammation drug for external use Download PDF

Info

Publication number
CN105395930A
CN105395930A CN201510851346.7A CN201510851346A CN105395930A CN 105395930 A CN105395930 A CN 105395930A CN 201510851346 A CN201510851346 A CN 201510851346A CN 105395930 A CN105395930 A CN 105395930A
Authority
CN
China
Prior art keywords
parts
herba
rhizoma
external use
medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510851346.7A
Other languages
Chinese (zh)
Inventor
梁苡玮
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201510851346.7A priority Critical patent/CN105395930A/en
Publication of CN105395930A publication Critical patent/CN105395930A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention provides an antisepsis and anti-inflammation drug for external use. The antisepsis and anti-inflammation drug is prepared from common cnidium fruits, folium artemisiae argyi, artemisia apiacea, nutmeg, desmodium styracifolium, pyrrosia lingua, abrus cantoniensis hance, poria cocos, herbs of lygodium japonicum, lalang grass rhizome, bark of ash, hairyvein agrimony, roots of Chinese pulsatilla, bock greenbrier rhizome, coptidis rhizoma, rhizoma artactyloidis, radix sophorae flavescentis, Chinese blister beetle, Chinese azalea flowers and croton. A preparation method for the drug for external use comprises the steps that after the raw materials are firstly soaked with water for 5-10 days, the raw materials are placed in a hot pot to be stir-fried, coconut oil is added along with stir-frying, the raw materials are taken out to be cooled, and then the raw materials are added to an alcoholic solution to be soaked for 10-30 days. The antisepsis and anti-inflammation drug for external use is small in toxic and side effect, fast in effect taking and good in curative effect.

Description

The medicine for external use of anti-inflammation
Technical field
The present invention relates to a kind of medicine for external use of anti-inflammation, belong to technical field of Chinese medicines.
Background technology
Along with all kinds of antibiotic continuous appearance such as penicillins, bacterial infection disease obtains effective control, thus antibiotic is become powerful mean that the mankind resist pathogenic bacterial infection.But in recent years, people use antibiotic to cause the drug resistance of antibacterial constantly to strengthen for a long time widely, and Resistant frequency increases gradually, so that conventional antibiotic cannot meet clinical needs.Thus, people are badly in need of one can solve drug resistance, effectively can cure various infectious skin disease again and anti-inflammation product to human body fanout free region.
Summary of the invention
The technical problem to be solved in the present invention is: the medicine for external use providing a kind of anti-inflammation, has that toxic and side effects is little, the advantage such as instant effect and good effect.
For solving the problems of the technologies described above, the present invention by the following technical solutions:
The medicine for external use of anti-inflammation, is obtained by the raw material of following weight parts:
Fructus Cnidii 20 ~ 30 parts, Folium Artemisiae Argyi 20 ~ 30 parts, Herba Artemisiae Annuae 20 ~ 30 parts, Semen Myristicae 20 ~ 30 parts, Herba Desmodii Styracifolii 20 ~ 30 parts, Folium Pyrrosiae 10 ~ 20 parts, Herba Abri 10 ~ 20 parts, 10 ~ 20 parts, Poria, Herba lygodii 10 ~ 20 parts, Rhizoma Imperatae 10 ~ 20 parts, Cortex Fraxini 1 ~ 10 part, Herba Agrimoniae 1 ~ 10 part, the Radix Pulsatillae 1 ~ 10 part, Rhizoma Smilacis Bockii 1 ~ 10 part, Rhizoma Coptidis 1 ~ 10 part, Rhizoma Atractylodis 1 ~ 10 part, Radix Sophorae Flavescentis 1 ~ 10 part, Mylabris 0.1 ~ 1 part, Flos Rhododendri Mollis 0.1 ~ 1 part, Fructus Crotonis 0.1 ~ 1 part.
As preferably, provide a concrete formula here, the weight portion of described raw material is:
Fructus Cnidii 25 parts, Folium Artemisiae Argyi 30 parts, Herba Artemisiae Annuae 20 parts, Semen Myristicae 25 parts, Herba Desmodii Styracifolii 30 parts, Folium Pyrrosiae 10 parts, Herba Abri 15 parts, 20 parts, Poria, Herba lygodii 10 parts, Rhizoma Imperatae 15 parts, Cortex Fraxini 10 parts, Herba Agrimoniae 1 part, the Radix Pulsatillae 5 parts, Rhizoma Smilacis Bockii 10 parts, Rhizoma Coptidis 1 part, Rhizoma Atractylodis 5 parts, Radix Sophorae Flavescentis 10 parts, Mylabris 0.1 part, Flos Rhododendri Mollis 0.5 part, Fructus Crotonis 1 part.
As preferably, provide second concrete formula here, the weight portion of described raw material is:
Fructus Cnidii 20 parts, Folium Artemisiae Argyi 25 parts, Herba Artemisiae Annuae 30 parts, Semen Myristicae 20 parts, Herba Desmodii Styracifolii 25 parts, Folium Pyrrosiae 20 parts, Herba Abri 10 parts, 15 parts, Poria, Herba lygodii 20 parts, Rhizoma Imperatae 10 parts, Cortex Fraxini 5 parts, Herba Agrimoniae 10 parts, the Radix Pulsatillae 1 part, Rhizoma Smilacis Bockii 5 parts, Rhizoma Coptidis 10 parts, Rhizoma Atractylodis 1 part, Radix Sophorae Flavescentis 5 parts, Mylabris 1 part, Flos Rhododendri Mollis 0.1 part, Fructus Crotonis 0.5 part.
As preferably, provide the 3rd concrete formula here, the weight portion of described raw material is:
Fructus Cnidii 30 parts, Folium Artemisiae Argyi 20 parts, Herba Artemisiae Annuae 25 parts, Semen Myristicae 30 parts, Herba Desmodii Styracifolii 20 parts, Folium Pyrrosiae 15 parts, Herba Abri 20 parts, 10 parts, Poria, Herba lygodii 15 parts, Rhizoma Imperatae 20 parts, Cortex Fraxini 1 part, Herba Agrimoniae 5 parts, the Radix Pulsatillae 10 parts, Rhizoma Smilacis Bockii 1 part, Rhizoma Coptidis 5 parts, Rhizoma Atractylodis 10 parts, Radix Sophorae Flavescentis 1 part, Mylabris 0.5 part, Flos Rhododendri Mollis 1 part, Fructus Crotonis 0.1 part.
The present invention also provides the preparation method of above-mentioned medicine for external use, its step the following is: by raw material with the water soak at room temperature of its weight 5 ~ 10 times after 5 ~ 10 days, taking-up drains, then be placed in 270 ~ 280 DEG C of hot pots to stir-fry 10 ~ 20 minutes, then after adding the Oleum Cocois of its weight 0.1% ~ 1%, continue to stir-fry 10 ~ 20 minutes, after taking out cooling, the volumetric concentration adding its weight 3 ~ 8 times is in the alcoholic solution of 40% ~ 70%, soaks after 10 ~ 30 days and namely obtains this medicine for external use.
The using method of this medicine for external use is: medicated wine uniform application immersion obtained is in affected part, and dosage is for be no more than 20mL at every turn.
The invention has the beneficial effects as follows: raw material of the present invention is conventional Chinese herbal medicine, wide material sources, low price; Preparation method of the present invention is simple, the scientific formulation of medicine is reasonable, synergism between each component, and obtained medicine has the effect of good antibacterial, antiinflammatory, detumescence, pain relieving, hemostasis, convergence and removing the necrotic tissue and promoting granulation, be specially adapted to the antiphlogistic antibacterial of body surface, there is advantage that is effective, instant effect.
Detailed description of the invention
Further illustrate the present invention by the following examples, but the invention is not restricted to these embodiments.
Embodiment 1
The medicine for external use of anti-inflammation, is obtained by the raw material of following weight parts: Fructus Cnidii 25 parts, Folium Artemisiae Argyi 30 parts, Herba Artemisiae Annuae 20 parts, Semen Myristicae 25 parts, Herba Desmodii Styracifolii 30 parts, Folium Pyrrosiae 10 parts, Herba Abri 15 parts, 20 parts, Poria, Herba lygodii 10 parts, Rhizoma Imperatae 15 parts, Cortex Fraxini 10 parts, Herba Agrimoniae 1 part, the Radix Pulsatillae 5 parts, Rhizoma Smilacis Bockii 10 parts, Rhizoma Coptidis 1 part, Rhizoma Atractylodis 5 parts, Radix Sophorae Flavescentis 10 parts, Mylabris 0.1 part, Flos Rhododendri Mollis 0.5 part, Fructus Crotonis 1 part.
The preparation method of medicine for external use is: by raw material with the water soak at room temperature of its weight 5 times after 8 days, taking-up drains, then be placed in 270 ~ 280 DEG C of hot pots to stir-fry 20 minutes, then after adding the Oleum Cocois of its weight 0.1%, continue to stir-fry 20 minutes, after taking out cooling, the volumetric concentration adding its weight 5 times is in the alcoholic solution of 70%, soaks after 10 days and namely obtains this medicine for external use.
Embodiment 2
The medicine for external use of anti-inflammation, is obtained by the raw material of following weight parts: Fructus Cnidii 20 parts, Folium Artemisiae Argyi 25 parts, Herba Artemisiae Annuae 30 parts, Semen Myristicae 20 parts, Herba Desmodii Styracifolii 25 parts, Folium Pyrrosiae 20 parts, Herba Abri 10 parts, 15 parts, Poria, Herba lygodii 20 parts, Rhizoma Imperatae 10 parts, Cortex Fraxini 5 parts, Herba Agrimoniae 10 parts, the Radix Pulsatillae 1 part, Rhizoma Smilacis Bockii 5 parts, Rhizoma Coptidis 10 parts, Rhizoma Atractylodis 1 part, Radix Sophorae Flavescentis 5 parts, Mylabris 1 part, Flos Rhododendri Mollis 0.1 part, Fructus Crotonis 0.5 part.
The preparation method of medicine for external use is: by raw material with the water soak at room temperature of its weight 8 times after 10 days, taking-up drains, then be placed in 270 ~ 280 DEG C of hot pots to stir-fry 10 minutes, then after adding the Oleum Cocois of its weight 0.5%, continue to stir-fry 10 minutes, after taking out cooling, the volumetric concentration adding its weight 8 times is in the alcoholic solution of 40%, soaks after 20 days and namely obtains this medicine for external use.
Embodiment 3
The medicine for external use of anti-inflammation, is obtained by the raw material of following weight parts: Fructus Cnidii 30 parts, Folium Artemisiae Argyi 20 parts, Herba Artemisiae Annuae 25 parts, Semen Myristicae 30 parts, Herba Desmodii Styracifolii 20 parts, Folium Pyrrosiae 15 parts, Herba Abri 20 parts, 10 parts, Poria, Herba lygodii 15 parts, Rhizoma Imperatae 20 parts, Cortex Fraxini 1 part, Herba Agrimoniae 5 parts, the Radix Pulsatillae 10 parts, Rhizoma Smilacis Bockii 1 part, Rhizoma Coptidis 5 parts, Rhizoma Atractylodis 10 parts, Radix Sophorae Flavescentis 1 part, Mylabris 0.5 part, Flos Rhododendri Mollis 1 part, Fructus Crotonis 0.1 part.
The preparation method of medicine for external use is: by raw material with the water soak at room temperature of its weight 10 times after 5 days, taking-up drains, then be placed in 270 ~ 280 DEG C of hot pots to stir-fry 15 minutes, then after adding the Oleum Cocois of its weight 1%, continue to stir-fry 10 minutes, after taking out cooling, the volumetric concentration adding its weight 5 times is in the alcoholic solution of 50%, soaks after 30 days and namely obtains this medicine for external use.
Toxicity test
Get ICR mice, before experiment, water 15h is can't help in fasting, is divided into 19 groups (the test medicine for external use group 6 groups of each embodiment, matched groups 1 group).Each group of mouse tail vein administration, test 1 group and be all according to dosage respectively 500mg/kg, 1000mg/kg, 2000mg/kg, 5000mg/kg, 10000mg/kg, 20000mg/kg to test 6 groups of dosages, control group mice gives same volume distilled water.Examine and record administration at once to toxic reaction and the death condition of mice appearance in 7d; Bliss ' s method is adopted to calculate LD50.The following form of experimental result:
Group mg/kg
Embodiment 1 medicine for external use 3848.76
Embodiment 2 medicine for external use 3985.33
Embodiment 3 medicine for external use 3970.01
The LD50 of this medicine for external use is at more than 3848mg/kg as seen from the above table, and obviously the toxicity of this medicine for external use is very low, and this medicine for external use is based on external, in the rational scope of application, can ignore to the toxic and side effects of human body.
Therapeutic effect
Use the obtained medicine for external use of embodiment 1 to have the patient of inflammation to carry out proof test to 180 body surfaces, average cure rate is at least 90.6%.Wherein: to be less than in 30 people of 20 years old 29 people's recoveries from illness, wherein 1 people because taking other drug, drug withdrawal is invalid; In 30 people of 20 ~ 30 years old 28 people recovery from illness, wherein 1 people because of conceived drug withdrawal invalid; In 30 people of 30 ~ 40 years old 28 people recovery from illness, wherein 1 people because taking other drug, drug withdrawal is invalid; In 30 people of 40 ~ 50 years old 27 people recovery from illness, wherein 1 people because taking other drug, drug withdrawal is invalid; 26 people's recoveries from illness in 30 people of 50 ~ 60 years old, wherein 3 people drug withdrawal because taking other drug; 25 people's recoveries from illness in 30 people of more than 60 years old, wherein 4 people take other drug and drug withdrawal is invalid.

Claims (5)

1. the medicine for external use of anti-inflammation, is characterized in that, is obtained by the raw material of following weight parts:
Fructus Cnidii 20 ~ 30 parts, Folium Artemisiae Argyi 20 ~ 30 parts, Herba Artemisiae Annuae 20 ~ 30 parts, Semen Myristicae 20 ~ 30 parts, Herba Desmodii Styracifolii 20 ~ 30 parts, Folium Pyrrosiae 10 ~ 20 parts, Herba Abri 10 ~ 20 parts, 10 ~ 20 parts, Poria, Herba lygodii 10 ~ 20 parts, Rhizoma Imperatae 10 ~ 20 parts, Cortex Fraxini 1 ~ 10 part, Herba Agrimoniae 1 ~ 10 part, the Radix Pulsatillae 1 ~ 10 part, Rhizoma Smilacis Bockii 1 ~ 10 part, Rhizoma Coptidis 1 ~ 10 part, Rhizoma Atractylodis 1 ~ 10 part, Radix Sophorae Flavescentis 1 ~ 10 part, Mylabris 0.1 ~ 1 part, Flos Rhododendri Mollis 0.1 ~ 1 part, Fructus Crotonis 0.1 ~ 1 part.
2. medicine for external use according to claim 1, is characterized in that, the weight portion of described raw material is:
Fructus Cnidii 25 parts, Folium Artemisiae Argyi 30 parts, Herba Artemisiae Annuae 20 parts, Semen Myristicae 25 parts, Herba Desmodii Styracifolii 30 parts, Folium Pyrrosiae 10 parts, Herba Abri 15 parts, 20 parts, Poria, Herba lygodii 10 parts, Rhizoma Imperatae 15 parts, Cortex Fraxini 10 parts, Herba Agrimoniae 1 part, the Radix Pulsatillae 5 parts, Rhizoma Smilacis Bockii 10 parts, Rhizoma Coptidis 1 part, Rhizoma Atractylodis 5 parts, Radix Sophorae Flavescentis 10 parts, Mylabris 0.1 part, Flos Rhododendri Mollis 0.5 part, Fructus Crotonis 1 part.
3. medicine for external use according to claim 1, is characterized in that, the weight portion of described raw material is:
Fructus Cnidii 20 parts, Folium Artemisiae Argyi 25 parts, Herba Artemisiae Annuae 30 parts, Semen Myristicae 20 parts, Herba Desmodii Styracifolii 25 parts, Folium Pyrrosiae 20 parts, Herba Abri 10 parts, 15 parts, Poria, Herba lygodii 20 parts, Rhizoma Imperatae 10 parts, Cortex Fraxini 5 parts, Herba Agrimoniae 10 parts, the Radix Pulsatillae 1 part, Rhizoma Smilacis Bockii 5 parts, Rhizoma Coptidis 10 parts, Rhizoma Atractylodis 1 part, Radix Sophorae Flavescentis 5 parts, Mylabris 1 part, Flos Rhododendri Mollis 0.1 part, Fructus Crotonis 0.5 part.
4. medicine for external use according to claim 1, is characterized in that, the weight portion of described raw material is:
Fructus Cnidii 30 parts, Folium Artemisiae Argyi 20 parts, Herba Artemisiae Annuae 25 parts, Semen Myristicae 30 parts, Herba Desmodii Styracifolii 20 parts, Folium Pyrrosiae 15 parts, Herba Abri 20 parts, 10 parts, Poria, Herba lygodii 15 parts, Rhizoma Imperatae 20 parts, Cortex Fraxini 1 part, Herba Agrimoniae 5 parts, the Radix Pulsatillae 10 parts, Rhizoma Smilacis Bockii 1 part, Rhizoma Coptidis 5 parts, Rhizoma Atractylodis 10 parts, Radix Sophorae Flavescentis 1 part, Mylabris 0.5 part, Flos Rhododendri Mollis 1 part, Fructus Crotonis 0.1 part.
5. the medicine for external use according to any one of Claims 1 to 4, is characterized in that, the preparation method of this medicine for external use is:
By raw material with the water soak at room temperature of its weight 5 ~ 10 times after 5 ~ 10 days, taking-up drains, then be placed in 270 ~ 280 DEG C of hot pots to stir-fry 10 ~ 20 minutes, then after adding the Oleum Cocois of its weight 0.1% ~ 1%, continue to stir-fry 10 ~ 20 minutes, after taking out cooling, the volumetric concentration adding its weight 3 ~ 8 times is in the alcoholic solution of 40% ~ 70%, soaks after 10 ~ 30 days and namely obtains this medicine for external use.
CN201510851346.7A 2015-11-30 2015-11-30 Antisepsis and anti-inflammation drug for external use Pending CN105395930A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510851346.7A CN105395930A (en) 2015-11-30 2015-11-30 Antisepsis and anti-inflammation drug for external use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510851346.7A CN105395930A (en) 2015-11-30 2015-11-30 Antisepsis and anti-inflammation drug for external use

Publications (1)

Publication Number Publication Date
CN105395930A true CN105395930A (en) 2016-03-16

Family

ID=55461918

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510851346.7A Pending CN105395930A (en) 2015-11-30 2015-11-30 Antisepsis and anti-inflammation drug for external use

Country Status (1)

Country Link
CN (1) CN105395930A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106265377A (en) * 2016-10-13 2017-01-04 张佳恩 A kind of compositions with antiseptic activity and its preparation method and application

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1927328A (en) * 2005-09-09 2007-03-14 王向东 Traditional Chinese medicine composition for treating hemorrhoid, anus and pudendum disease and its using method
CN102166177A (en) * 2011-04-07 2011-08-31 深圳清华大学研究院 Chinese medicinal extract, and hand washing gel and preparation method thereof
CN103705773A (en) * 2013-12-30 2014-04-09 广西梧州制药(集团)股份有限公司 Traditional Chinese medicine composition for achieving antibacterial and anti-inflammation effects and preparation method thereof
CN103784771A (en) * 2011-06-29 2014-05-14 纽素乐必佳(天津)药业集团有限公司 Traditional Chinese medicine composition has functions of anticoccidia, haemostasis and blood enriching, and antibiosis and antiphlogosis, and preparation method thereof
CN104706721A (en) * 2013-12-14 2015-06-17 淄博开发区亚大制药有限责任公司 Antibacterial and inflammation-eliminating traditional Chinese medicine composition

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1927328A (en) * 2005-09-09 2007-03-14 王向东 Traditional Chinese medicine composition for treating hemorrhoid, anus and pudendum disease and its using method
CN102166177A (en) * 2011-04-07 2011-08-31 深圳清华大学研究院 Chinese medicinal extract, and hand washing gel and preparation method thereof
CN103784771A (en) * 2011-06-29 2014-05-14 纽素乐必佳(天津)药业集团有限公司 Traditional Chinese medicine composition has functions of anticoccidia, haemostasis and blood enriching, and antibiosis and antiphlogosis, and preparation method thereof
CN104706721A (en) * 2013-12-14 2015-06-17 淄博开发区亚大制药有限责任公司 Antibacterial and inflammation-eliminating traditional Chinese medicine composition
CN103705773A (en) * 2013-12-30 2014-04-09 广西梧州制药(集团)股份有限公司 Traditional Chinese medicine composition for achieving antibacterial and anti-inflammation effects and preparation method thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
刘云峣等: "《中国历代中医格言大观》", 31 March 1992, 文汇出版社 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106265377A (en) * 2016-10-13 2017-01-04 张佳恩 A kind of compositions with antiseptic activity and its preparation method and application
CN106265377B (en) * 2016-10-13 2019-03-12 浙江悦萱堂化妆品有限公司 A kind of composition and its preparation method and application with antiseptic activity

Similar Documents

Publication Publication Date Title
CN101711796A (en) Application of scullcapflavone in preparing medicament for treating enterovirus infection
CN105395930A (en) Antisepsis and anti-inflammation drug for external use
CN108066536A (en) A kind of orthopedics plaster
CN107890486B (en) Traditional Chinese medicine external anti-inflammation preparation and preparation method and application thereof
CN103536850B (en) A kind of Chinese medicine of internal and external application treatment verruca plana
CN101391065B (en) Compound momordica seed pepper soup for treating urgent chronic pelvic inflammatory disease
CN1276763C (en) Chinese traditional medicine composition for treating bedsore and acute soft tissue injury
CN108785363A (en) Application of the yellow wingceltis platymiscium perfume (or spice) material in the drug for preparing treatment microorganism infection
CN105412455A (en) Swelling reducing and pain relieving medicine for external use
CN1903352A (en) Medicine for treating beriberi
CN108066541A (en) A kind of preparation method of orthopedics plaster
CN105311211A (en) Medicine for treating scald
CN103083551B (en) Traditional Chinese medicine composition for treating infantile suppurative tonsillitis
CN105311473A (en) Rapid hemostasis drug
CN1322893C (en) Acne eliminating tablet and its prepn process
CN105395987A (en) Externally-applied agent for sterilization and itching relieving
CN104189273A (en) Traditional Chinese medicine used for treating thrombophlebitis
CN104510955A (en) Traditional Chinese medicine formula for treating beriberi
CN105853556A (en) Medicine for treating fungal, viral and bacterial skin disease and sexual skin disease
CN102416087A (en) Chinese medicinal composition for treating pelvic inflammatory disease and preparation method as well as application thereof
CN105395929A (en) Externally-applied agent for removing scars
CN105396099A (en) Externally-applied agent for treatment of frostbite
CN105311512A (en) Medicine for treating onychomycosis
CN104435835A (en) Traditional Chinese medicine lotion used for treating pediatric hand-foot-and-mouth disease
CN103316093B (en) Chinese medicinal preparation for treating chemotherapy-induced superficial thrombophlebitis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
DD01 Delivery of document by public notice

Addressee: Liang Yiwei

Document name: Notification of Passing Examination on Formalities

C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20160316